Thomas Chen, MD, PhD
NeOnc Technologies Holdings, Inc.
2
0
0
N/A
0
9
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (2)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Josh Neman, PhD
NeOnc Technologies Holdings, Inc.
Shared therapeutic areas:
Worked with same sponsors:
Maryam Fouladi, MD
Nationwide Children's Hospital
Shared therapeutic areas:
Jiayi Huang, M.D.
Washington University School of Medicine
Shared therapeutic areas:
Sean Grimm, MD
Northwestern University
Shared therapeutic areas:
Steven Chmura, MD
University of Chicago
Shared therapeutic areas:
Gustavo Leone
Medical University of South Carolina, Hollings Cancer Center
Shared therapeutic areas:
Jeffrey Raizer, MD
Northwestern University
Shared therapeutic areas:
Adam Mamelak, MD
Cedars-Sinai Medical Center
Shared therapeutic areas:
Stanislaw R. Burzynski, MD, PhD
Burzynski Research Institute
Shared therapeutic areas:
Bilal Omer, MD
Baylor College of Medicine
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain Tumors
Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma
All 2 trials loaded